← SynDRA
DOCEBENONE
SynDRA canonical compound SYN0003103 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | ALOX5 |
| Mechanism of action | lipoxygenase inhibitor |
All known targets
Mechanisms of action (all sources)
- lipoxygenase inhibitor
- ALOX5 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- NR1I2
- ALDH1A1
- POLH
- MPHOSPH8
- MTOR
- NFKB1
- NPSR1
- PLK1
- PMP22
- POLB
- POLI
- MAPK1
- PTH1R
- RGS4
- SMAD3
- SMN1
- TBXAS1
- TDP1
- TSHR
- USP1
- MAPT
- LMNA
- ALOX15
- CYP2C9
- APEX1
- ARSA
- ATAD5
- ATXN2
- BAZ2B
- BLM
- CBX1
- CYP2C19
- CYP2D6
- KDM4E
- CYP3A4
- EHMT2
- FEN1
- GMNN
- HIF1A
- HPGD
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ADCY9
- ESRRA
- SMAD2
- PPARG
- NSD2
- NF2L2
- KSYK
- KCNK3
- GLSK
- G3P
- FUMH
- ESR2
- AHR
- ESR1
- CP3A7
- CP3A4
- CP2D6
- CP2CJ
- CP2C9
- CP1A2
- CAC1H
- ANDR
- SYK
Drug classes
Cross-references
Synonyms
- Docebenona
- A-61589
- AA-861
- Docebenonum
- AA861
- Docebenone [USAN:INN]
- Docebenonum [INN-Latin]
- Docebenona [INN-Spanish]
- UNII-2XRX3BD53M
- 2-(12-hydroxydodeca-5,10-diyn-1-yl)-3,5,6-trimethylcyclohexa-2,5-diene-1,4-dione
- CHEBI:2340
- A 61589
- 2-(12-Hydroxy-5,10-dodecadiynyl)-3,5,6-trimethyl-p-benzoquinone
- 2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone
- 2XRX3BD53M
- MLS000028467
- NCGC00015053-05
- SMR000058412
- 2-(12-hydroxydodeca-5,10-diynyl)-3,5,6-trimethyl-1,4-benzoquinone
- AA 861
- DTXCID8025125
- RefChem:590025
- CAS-80809-81-0
- Docembenone
- DOCEBENONE [INN]
- Docebenone (USAN/INN)
- Opera_ID_1818
- DOCEBENONE [USAN]
- Lopac-A-3711
- DOCEBENONE [MART.]
- Lopac0_000026
- BSPBio_001266
- KBioGR_000606
- KBioSS_000606
- SCHEMBL522781
- orb1707367
- KBio2_000606
Look up DOCEBENONE in the interactive SynDRA portal →